Skip to main content

. 1994 Jan;57(1):119–120. doi: 10.1136/jnnp.57.1.119-a

Changes in CSF amino acid concentrations during the evolution of amyotrophic lateral sclerosis.

O Blin, D Samuel, A Nieoullon, G Serratice

PMCID: PMC485053 PMID: 8301293

119

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Nakano Y., Hirayama K., Terao K. Hepatic ultrastructural changes and liver dysfunction in amyotrophic lateral sclerosis. Arch Neurol. 1987 Jan;44(1):103–106. doi: 10.1001/archneur.1987.00520130079022. [DOI] [PubMed] [Google Scholar]
Perry T. L., Krieger C., Hansen S., Eisen A. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid. Ann Neurol. 1990 Jul;28(1):12–17. doi: 10.1002/ana.410280105. [DOI] [PubMed] [Google Scholar]
Plaitakis A., Caroscio J. T. Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1987 Nov;22(5):575–579. doi: 10.1002/ana.410220503. [DOI] [PubMed] [Google Scholar]
Plaitakis A., Constantakakis E., Smith J. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis. Ann Neurol. 1988 Sep;24(3):446–449. doi: 10.1002/ana.410240314. [DOI] [PubMed] [Google Scholar]
Rothstein J. D., Tsai G., Kuncl R. W., Clawson L., Cornblath D. R., Drachman D. B., Pestronk A., Stauch B. L., Coyle J. T. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1990 Jul;28(1):18–25. doi: 10.1002/ana.410280106. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES